Medium materiality6/10
Abivax price target lowered to $151 from $155 at Truist
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Truist lowers ABVX target to $151 from $155; current price $103.45; -5.34 since signal.
- Truist lowers ABVX target to $151 from $155; price $103.45.
Key facts
- 01
Target: $151
- 02
Posted price: $103.45
- 03
Analyst firm: Truist Financial
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.